Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Parenteral Nutrition Market, Nutrient Type
7.1. Parenteral Nutrition Market, Nutrient Type, 2020-2028
7.1.1. Carbohydrates
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Lipid Emulsion
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Single Dose Amino Acid Solution
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Trace Elements
7.1.4.1. Market Revenue and Forecast (2016-2028)
7.1.5. Vitamins & Minerals
7.1.5.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Parenteral Nutrition Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.2. Europe
8.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3. APAC
8.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4. MEA
8.4.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.5. Latin America
8.5.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, Nutrient Type (2016-2028)
Chapter 9. Company Profiles
9.1. Baxter International Inc.
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Grifols International S.A.
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Actavis Inc.
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. B. Braun Melsungen AG
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Fresenius Kabi AG
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Hospira Inc.
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms